KOF logo

KOF Net Receivables

Latest reported$27.31B MXN
KOF Quarterly Net Receivables · MXN ($141.69M → $27.31B)
High-resolution chart · PNG

KOF net receivables history

Quarterly · MXN. Dates are reporting period ends; fiscal years can differ from calendar years.

Coca Cola Femsa S.A.B. de C.V. American Depositary Shares, each representing 10 Units (each Unit consists of 3 Series B Shares and 5 Series L Shares) Net Receivables — Quarterly (MXN)
Period endingNet Receivables (MXN)
27,311,198,000
26,587,542,000
29,842,425,000
25,172,881,000
22,915,664,000
23,993,767,000
25,403,000,000
21,910,560,000
21,240,785,000
21,140,695,000
23,174,000,000
18,401,750,000
18,525,582,000
19,205,030,000
22,230,000,000
19,774,496,000
17,287,231,000
17,256,058,000
18,307,000,000
12,879,019,000
14,199,021,000
13,271,781,000
16,994,000,000
15,149,414,000
14,325,726,000
17,548,544,000
23,043,000,000
18,772,546,000
17,646,205,000
16,581,984,000
20,885,000,000
18,312,231,000
19,111,900,000
20,102,816,000
22,748,000,000
17,373,431,000
15,182,198,000
16,631,359,000
19,500,155,000
13,704,935,000
8,829,000,000
8,427,000,000
13,867,000,000
7,092,000,000
7,637,000,000
7,035,000,000
14,421,000,000
8,647,000,000
8,173,000,000
7,861,000,000
14,031,000,000
7,419,000,000
10,406,000,000
7,226,000,000
11,984,000,000
7,814,000,000
6,935,000,000
6,626,000,000
10,821,000,000
6,034,000,000
5,034,000,000
5,218,000,000
8,366,000,000
4,753,000,000
4,118,000,000
4,441,000,000
7,707,000,000
6,066,000,000
4,011,000,000
3,962,000,000
6,182,000,000
4,200,000,000
4,201,992,000
3,924,500,000
4,498,809,000
2,973,235,000
2,556,045,000
2,782,284,000
3,206,115,000
2,162,075,000
2,079,030,000
1,977,612,000
3,248,190,000
1,763,820,000
1,750,050,000
1,706,325,000
2,833,340,000
2,327,456,000
2,809,920,000
2,327,652,000
1,812,942,000
2,583,713,000
1,746,973,000
616,767,122
755,459,711
610,417,945
729,674,595
678,119,630
915,561,296
632,738,340
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.